Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
GMAB
Genmab A/S ADS
$33.56
Login to see Genmab A/S ADS (GMAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Technical Indicators
5+ Days Up
Chart
$27.83 (+20.59%)
$21.46 (+56.38%)
$19.17 (+75.07%)
$22.98 (+46.04%)
GMAB has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
GMAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
GMAB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMAB Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayGMAB Earnings
The TTM reflects 12-month period, providing review of GMAB financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is GMAB current stock price?
What are GMAB stock strengths?
What risks are associated with GMAB stock?
When is GMAB next earnings report?
What is GMAB market cap and volume?
What is GMAB's current Stock IQ?
Should I buy GMAB stock right now?
Is GMAB a Strong Buy right now?
What does a 'Strong Buy' rating mean for GMAB?
What does a 'Strong Sell' rating mean for GMAB?
What factors influence GMAB's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
GMAB
Genmab A/S ADS
Current Price
$33.56
Stock Insights
Technical Indicators
5+ Days Up
Login to unlock Genmab A/S ADS (GMAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$27.83 (+20.59%)
$21.46 (+56.38%)
$19.17 (+75.07%)
$22.98 (+46.04%)
GMAB Analysts Opinion
GMAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
GMAB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMAB Street view is extremely bullish and have negative views on the near-term outlook
GMAB has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayGMAB Earnings
The TTM data reflects the most recent 12-month period, providing overview of GMAB financial performance.
GMAB Financial Health
The company financial health has moderately improved over the past year
Financial Score
GMAB Latest Analysis
What Makes Genmab A/S Sponsored ADR (GMAB) a Strong Momentum Stock: Buy Now?. Does Genmab A/S Sponsored ADR (GMAB) have what it takes to be a top stock pick for momentum investors? Lets find out.
Today
Genmab In Advanced Talks To Acquire Merus : Report . (RTTNews) - Denmarks Genmab A/S (GMAB) is in advanced negotiations to acquire Merus NV (MRUS) a Dutch biopharmaceutical company developing treatments for head and neck cancer Bloomberg reported citing people familiar with the matter.
Mon Sep 29, 2025
Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2025 Transcript.
Thu Sep 25, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GMAB Stock trends
GMAB Stock performance
GMAB Stock analysis
GMAB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings